BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/75/0.1/20.12.24 | Real-time Bid/Ask 09:11:04 04/07/2024 BST | ||
| 0.154 EUR / 0.164 EUR | +11.19% |
|
| Current month | +7.52% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 04/07/24 | 0.157 | +9.79% |
| 03/07/24 | 0.143 | -18.75% |
| 02/07/24 | 0.176 | +23.94% |
| 01/07/24 | 0.142 | +6.77% |
| 28/06/24 | 0.133 | -15.82% |
Delayed Quote Börse Stuttgart
Last update July 04, 2024 at 07:17 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VD8M1C |
| ISIN | DE000VD8M1C6 |
| Date issued | 24/06/2024 |
| Strike | 75 $ |
| Maturity | 20/12/2024 (170 Days) |
| Parity | 10 : 1 |
| Emission price | 0.15 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.176 € |
|---|---|
| Lowest since issue | 0.133 € |
| Spread | 0.01 € |
| Spread % | 6.06% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.08
USD
Average target price
96.13
USD
Spread / Average Target
+5.54%
- Stock Market
- Warrants
- Warrant
